Atlas Trials

A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

Clinical trial NCT05759273 · COMPLETED

Trial details

NCT number
NCT05759273
Sponsor
Ipsen
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2023-04-24
Primary completion
2024-09-30
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.